Amblyopia can possibly be avoided if it is detected early and treated appropriately. It remains to be decided whether the general population should be screened or whether a subpopulation of infants likely to develop this pathology can be isolated. A population study using the odds ratio was performed on a group of unselected infants (n = 2143) aged 5-15 months who attended a surveillance programme. Results show that a family history of visual defect has a 'protective' effect on individual infants, most probably because more of these infants are brought in for a check-up at an early age on the parents' initiative. The risk factor with the highest predisposition for amblyopia was found to be anisometropia. These results indicate the necessity for screening of refraction and resolution defects in the whole popUlation. The French health authorities have recently decided to provide for a visual assessment visit to all infants at the age of 9 months.
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Amblyopia is a reduction in visual capacity in one or both eyes that is not improved by refractive correction and occurs in the absence of detectable ocular pathology. Only developmental unilateral amblyopia is considered here. Detailed studies have shown that several aspects of visual function may be affected besides acuity. Usually the reduction in visual acuity, or a reduced contrast sensitivity for high spatial frequencies, is used to diagnose amblyo pia on the grounds that it is the visual function most accessible to commonly used tests (for a review see Levi and Carkeet l This paper describes an attempt to isolate the population of infants who would benefit from screening and surveillance programmes to prevent amblyopia by evaluating risks factors for amblyopia.
A clinical approach to eradicate this pathology, which affects some 3% of the population in the Western world, is described. There were approximately equal numbers of male and female infants.
METHODS AND POPULATION
It was deliberately advertised that the best age for visual assessment is around 9 months of age. Visits before the age of 7 months were discouraged unless the infant showed signs of strabismus or visual deficit.
As a consequence, the age distribution of our population is biased in favour of the range 8-11
months, which constitutes more than half of the total results.
An odds ratio estimates the probability of a pathology when exposed to a risk factor relative to the probability of pathology when not exposed to that risk factor. Exposure factors considered were family and personal history of general, visual and refractive disorders. The odds ratio quantifies the strength of the association between a factor (e.g.
hyperopia) and the occurrence of a pathology (e.g. amblyopia). The greater the amount by which the odds ratio exceeds 1, the more favourable the situation is for members of that group to develop the pathology. The greater the amount by which the odds ratio is less than 1, the more the situation is protective for the group. For an odds ratio of 0.5 the probability that the group will develop the pathology is half as great as that for the global population (protective effect). For an odds ratio of 2, the probability that the group will develop the pathology is twice as great as that for the global population (favouring effect).
The refractive errors considered as pathological are somewhat arbitrarily determined in infants, because the level of resolution is limited by retinal rather than optical factors. Values used here (hyperopia when refraction corrected for distance was �3 dioptres, myopia ::;:;0 dioptre, astigmatism < -lor> 1.5 dioptres, and anisometropia � 1 dioptre) are traditional. However, we analysed the data using three levels for hyperopia and anisometropia. Simi larly, the data concerning amblyopia consider two levels of the difference of resolution between the two eyes: one octave and one half-octave. Infants were not corrected during acuity assessment.
RESULTS

Incidence of Pathologies
The largest category of refractive pathology observed is anisometropia, then hyperopia, followed by astigmatism and myopia. Associations between these pathologies are illustrated in Fig. 1 N is the number of infants studied; the number in the lower part of the fIgure is increased because some infants with amblyopia andlor strabismus were emmetropes.
refractive errors in the population found to be amblyopic in our age range than in the non amblyopic population, and this difference is highly significant (Pearson KHI2 = 17.66 (5 degrees of freedom), p = 0.0034; Fig. 2 ). Nevertheless, 30% of our amblyopic infants were emmetropes. Conversely
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only 39% of non-amblyopic infants were emme tropes. Apart from the smaller proportion of emme tropes in the amblyopic group, the largest difference between the two groups is observed when comparing the group of anisometropic subjects (17% versus 7%).
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Fig . 2 . Proportion of refractive errors observed in the group of' amblyopic patients compared with the group of non amblyopjc subjects. 'Overlap' refers to infants showing more than one category of refractive error. .�
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Personal and family risk factors for amblyopia have been tested in the population under study. Fig. 3A shows that a family history of visual problems seems to be protective for the child, possibly through a selection artefact. No pathology reported by the parents has an effect favouring the occurrence of a pathology in the offspring. This protective effect, particularly significant when at least one first-degree relative is strabismic or amblyopic, means that these infants are apparently less prone to develop amblyo pia if the parents are affected by these pathologies.
The opposite is observed when personal history is considered (Fig. 3b) and personal refractive condi tion (Fig. 3c) . A report of crossed eyes and cerebral pathology on the one hand and anisometropia on the other are definitely factors favouring the occurrence of amblyopia.
DISCUSSION
Attendance
It is probable that our population is biased by several unknown factors. Obviously a large number of parents are worried that their child may have inherited their own visual problem, usually myopia, strabismus or amblyopia. Other infants were system atically referred if they had endured a difficult childbirth or had a birthweight under 1500 g. It could well be that the high proportion of those who attended with a family or personal history reflects some anxiety on the part of the parents. As a consequence the population studied is in no way representative of a general population. In any case it is likely that the bias bears more on the incidence of pathological cases than on the category of patholo gies. This is not a limitation of the scope of this study, which is an attempt to identify whether a categoryof infants can be isolated which would preferentially benefit from an early visual assessment.
Age at Visual Assessment
In the age range considered, infants around 9 months of age were very responsive to the acuity card procedure; they responded swiftly and complied more easily with orthoptic and ophthalmological examination than at a later age. This choice of age was also justified by the observation that occlusive or optical treatment is more readily accepted by the infant than after the age of 12 months or so. In addition, an occlusion 'dose' of 1 or 2 hours a day is very efficient at this early age in preventing or correcting amblyopia. It is easier for the parents tQ monitor this short duration of occlusion rather than the longer occlusion regime necessary at any later age. It is also easier to get the infant to accept spectacles, just as items of clothing are accepted, before he or she has constructed a better defined body image.
Risk Factors
The fact that the infants were not corrected for reported that perhaps one third of their amblyopic patients presented anisometropia but no strabismus.
Because, unfortunately, this defect is not detectable without a specific examination, it cannot be used to restrict an appropriate health strategy for the prevention of amblyopia to an 'at-risk' population.
It is confirmed that parental visual pathology has a 'protective' effect on the infants. An obvious hypothesis is that those parents are very aware of the inconvenience caused by their own visual problems and are very likely to have their children examined. Conversely, the population of infants most at risk of developing amblyopia is found in families devoid of visual pathology. In that group, the in cidence of amblyopia is low but the probability of it being identified is also very low. Because it is clear that amblyopia also occurs in infants with no parental history of visual defect, a strategy to detect all subjects who might be affected consists of providing visual assessment for the whole population. In conclusion, these data indicate the necessity for screening the whole population for refractive and res olution defects.
This is the new policy of the French national health authorities, who recently took the decision to offer a visual assessment at 9 months of age to all infants.
There remains the task of training sufficient special ists to provide this service throughout France.
Obviously, each country has different medical surveillance procedures and professional specialisa tion so that care is provided by various vision specialists. The next stages consist in designing efficient screening procedures and evaluating the cost of screening relative to the benefit of enhanced visual function over the life span.
